Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1976 Jun;13(6):1549–1553. doi: 10.1128/iai.13.6.1549-1553.1976

Cell-mediated immunity to varicella-zoster virus demonstrated by viral inactivation with human leukocytes.

A A Gershon, S Steinberg, M Smith
PMCID: PMC420798  PMID: 184040

Abstract

Cell-mediated immunity to varicella-zoster (V-Z) virus in persons immune to varicella has been demonstrated, using a tissue culture technique. Cell-mediated immunity was reflected by the ability of peripheral leukocytes (lymphocytes and monocytes) from human donors to inactivate V-Z virus. Leukocytes were stimulated by the addition of noninfectious V-Z antigen to cultures newly infected with V-Z virus. Several days leter, the V-Z virus in these cultures was titered. When leukocytes from donors immune to caricella were used, a significant decrease in V-Z titer, compared with controls, was noted. When leukocytes from donors susceptible to varicella were tested, no decrease in V-Z virus titer was found. A mixed population of lymphocytes and monocytes from immune donors was required to demonstrate inactivation of V-Z virus. The development of specific cell-mediated immunity to V-Z virus may play a role in termination of varicella and in prevention of second attacks of this disease.

Full text

PDF
1549

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong R. W., Merigan T. C. Varicella zoster virus: interferon production and comparative interferon sensitivity in human cell cultures. J Gen Virol. 1971 Jul;12(1):53–54. doi: 10.1099/0022-1317-12-1-53. [DOI] [PubMed] [Google Scholar]
  2. BRUNELL P. A., CASEY H. L. CRUDE TISSUE CULTURE ANTIGEN FOR DETERMINATION OF VARICELLA-ZOSTER COMPLEMENT FIXING ANTIBODY. Public Health Rep. 1964 Sep;79:839–842. [PMC free article] [PubMed] [Google Scholar]
  3. Brunell P. A., Gershon A. A. Passive immunization against varicella-zoster infections and other modes of therapy. J Infect Dis. 1973 Apr;127(4):415–423. doi: 10.1093/infdis/127.4.415. [DOI] [PubMed] [Google Scholar]
  4. Brunell P. A., Gershon A. A., Uduman S. A., Steinberg S. Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster. J Infect Dis. 1975 Jul;132(1):49–54. doi: 10.1093/infdis/132.1.49. [DOI] [PubMed] [Google Scholar]
  5. Gershon A. A., Krugman S. Seroepidemiologic survey of varicella: Value of specific fluorescent antibody test. Pediatrics. 1975 Dec;56(6):1005–1008. [PubMed] [Google Scholar]
  6. Jordan G. W., Merigan T. C. Cell-mediated immunity to varicella-zoster virus: in vitro lymphocyte responses. J Infect Dis. 1974 Nov;130(5):495–501. doi: 10.1093/infdis/130.5.495. [DOI] [PubMed] [Google Scholar]
  7. Koller C. A., King G. W., Hurtubise P. E., Sagone A. L., LoBuglio A. F. Characterization of glass adherent human mononuclear cells. J Immunol. 1973 Nov;111(5):1610–1612. [PubMed] [Google Scholar]
  8. Lodmell D. L., Notkins A. L. Cellular immunity to herpes simplex virus mediated by interferon. J Exp Med. 1974 Sep 1;140(3):764–778. doi: 10.1084/jem.140.3.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Russell A. S., Maini R. A., Bailey M., Dumonde D. C. Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles). Clin Exp Immunol. 1973 Jun;14(2):181–185. [PMC free article] [PubMed] [Google Scholar]
  10. Stevens D. A., Merigan T. C. Interferon, antibody, and other host factors in herpes zoster. J Clin Invest. 1972 May;51(5):1170–1178. doi: 10.1172/JCI106910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Williams V., Gershon A., Brunell P. A. Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence. J Infect Dis. 1974 Dec;130(6):669–672. doi: 10.1093/infdis/130.6.669. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES